Skip to search formSkip to main contentSkip to account menu

Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase

It is proposed that Ralteg Gravir, Paritaprevir, Bictegravir and DolutegravIR are excellent lead candidates for these crucial proteins and they could become potential therapeutic drugs against SARS-CoV-2.
View on Taylor & Francis (opens in a new tab)

Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an in silico assisted drug-repurposing study

It is proposed that Simeprevir and Paritaprevir are promising drug candidates to inhibit NSP15 and may act as potential therapeutic agents against SARS-CoV-2.
View on Taylor & Francis (opens in a new tab)

Targeting Novel Coronavirus 2019: A Systematic Drug Repurposing Approach to Identify Promising Inhibitors Against 3C-like Proteinase and 2'-O-Ribose Methyltransferase

It is proposed that Ralteg Gravir, Paritaprevir, Bictegravir and DolutegravIR are excellent lead candidates for these crucial proteins and they could become potential therapeutic drugs against 2019-nCoV.
View PDF (opens in a new tab)

A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods

This review provides comprehensive information of potential inhibitors identified through several computational methods thus far against 3CLpro from SARS-CoV-2 and provides a better understanding of their interaction patterns and dynamic states of free and ligand-bound 3CL Pro structures.
View on Springer (opens in a new tab)

Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA…

Four promising molecules were identified based on the estimated binding affinities and catalytic residue interactions and drug-like properties and suggested that ZINC19221101 and ZINC12454357 could act as most promising candidates for inhibiting the function of MurD ligase and aid in drug discovery and development against A.baumannii.
View on Springer (opens in a new tab)

Structure based in-silico study on UDP-N-acetylmuramoyl-L-alanyl-D-glutamate-2,6-diaminopimelate ligase (MurE) from Acinetobacter baumannii as a drug target against nosocomial infections

View via Publisher (opens in a new tab)

Screening of promising molecules against MurG as drug target in multi-drug-resistant-Acinetobacter baumannii - insights from comparative protein modeling, molecular docking and molecular dynamics…

Comparison protein modeling approach suggested that ZINC09186673 and ZINC09956120 are identified as most promising putative inhibitors for MurG protein in A. baumannii.
View on Taylor & Francis (opens in a new tab)

Identifying the natural compound Catechin from tropical mangrove plants as a potential lead candidate against 3CLpro from SARS-CoV-2: An integrated in silico approach

This study employed the structure-based virtual screening technique to evaluate an in-house library of antiviral compounds against 3CLpro of SARS-CoV-2 and proposes Catechin as a potential therapeutic agent against the virus.
View on Taylor & Francis (opens in a new tab)

Computer aided ligand based screening for identification of promising molecules against enzymes involved in peptidoglycan biosynthetic pathway from Acinetobacter baumannii.

View on PubMed (opens in a new tab)

Structure based drug designing and discovery of promising lead molecules against UDP-N-acetylenolpyruvoylglucosamine reductase (MurB): A potential drug target in multi-drug resistant Acinetobacter…

View on PubMed (opens in a new tab)
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)